Schedule 13G ownership disclosure
EPIRUS BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 29428P107
Event date: 2015-01-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.8800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001546927-15-000044
- Form type
- SC 13G
- Filer
- Camber Capital Management LP
- CIK
- CIK 1444043
- Filed
- Feb 09, 2015
- Reporting period
- Jan 30, 2015
- Description
- Schedule 13G beneficial ownership